Nuvalent, Inc. (NUVL)
102.83
+0.09
(+0.09%)
USD |
NASDAQ |
Apr 13, 13:44
Nuvalent EPS Diluted (Quarterly) : -1.585 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Glaukos Corp. | -2.324 |
| Edgewise Therapeutics, Inc. | -0.4737 |
| Cogent Biosciences, Inc. | -0.6934 |
| Neurocrine Biosciences, Inc. | 1.482 |
| Arcellx, Inc. | -1.003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -118.70M |
| Total Expenses (Quarterly) | 118.70M |
| Enterprise Value | 6.705B |
| Earnings Yield | -5.69% |
| Normalized Earnings Yield | -5.178 |